Proceedings of the Texas A&M Medical Student Grand Rounds

Redox Preconditioning Promotes the Survival of Cardiac Stem Cells Under Oxidative Stress After Transplantation

October 4, 2017 Melanie Kwan

Melanie Kwan

Introduction: Survival of cardiac stem cells (CSCs) after transplantation is necessary to facilitate cardiac repair following damage to the heart due to their potential ability to regenerate cardiomyocytes. The current best estimate of post-transplantation survival of CSCs is only approximately 10%.1 The primary cause of transplanted CSC death is oxidative stress induced by ischemia-reperfusion injury during cardiac surgery.1 Over-production of hydrogen peroxide (H2O2; one of the physiological oxidants in cells) caused by ischemia-reperfusion can induce further cardiac damage during surgery.2 Discovery of mechanisms that promote CSC survival under oxidative stress is needed to establish CSC transplantation as a viable treatment option. Previous studies used carbon monoxide (CO) pretreatment to induce a delayed cardioprotective effect by activating pro-survival signaling pathways in cardiomyocytes.3 Cai et. al. extended this concept to pretreatment with a heme oxygenase 1 inducer (CoPP), which induced endogenous CO generation to protect against ischemia-reperfusion injury.4 Teng et. al. expanded this further by pretreating CSCs with a nitric oxide (NO) donor to promote cell survival after CSC transplantation.2 Methods: Teng et. al. preconditioned CSCs with diethylenetriamine nitric oxide adduct (DETA-NO), a NO donor.2 The effect of H2O2-induced cellular damage was measured by lactate dehydrogenase (LDH) levels. To evaluate the functional role of DETA-NO preconditioning in promoting CSC survival, they stained cells with Annexin V-VITC and PI. to examine cell apoptosis.2 Results: DETA-NO pretreatment showed a time- and dose-dependent decrease of LDH release under H2O2-induced oxidative stress.2 The greatest reduction was seen with 12 h of preconditioning, and remained cytoprotective up to 24 h.2 The most effective time and dose combination in preventing cell death under oxidative stress was determined to be preconditioning CSCs for 12 h with 250 mM DETA-NO. Preconditioned cells, compared to controls, exhibited a reduction of 50% of total cell death when examining H2O2-induced apoptosis.2 Conclusion: Preconditioning CSCs with DETA-NO stimulates cell survival by activating multiple cell survival signaling pathways against oxidative stress, such as the NFkB, ERK, AKT, and STAT3 pathways.2 This promotes gene expression of the anti-apoptotic genes MCL, BCL-2, BCL-xL, and HO-1, leading to cytoprotection against oxidative stress and subsequently to increased CSC survival.2

  1. Cai C, Guo Y, Teng L, et al. Preconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart. Stem Cells. 2015;33(12):3596-3607.
  2. Teng L, Bennett E, Cai C. Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways. J Biol Chem. 2016;291(18):9733-9747.
  3. Stein AB, Bolli R, Dawn B, et al. Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol. 2012;52(1):228-236.
  4. Cai C, Teng L, Vu D, et al. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 2012;287(40):33720-33732.

 

Cardiology Stem Cells
Previous Post

The Effect of the DASH Diet on the Development of Inflammation and Hypertension

Next Post

Targeting miR-15a and miR-16 for Treatment in Multiple Cancers

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.